tiprankstipranks
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market
Want to see RAPP full AI Analyst Report?

Rapport Therapeutics, Inc. (RAPP) Ownership - Who Owns Rapport Therapeutics, Inc.?

152 Followers

Rapport Therapeutics, Inc. (RAPP) Ownership Overview

22.31%24.32%29.16%8.95%15.25%
22.31% Insiders
29.16% Other Institutional Investors
8.95% ETFs
15.25% Public Companies and
Individual Investors
The ownership structure of Rapport Therapeutics, Inc. (RAPP) stock is a mix of institutional, retail, and individual investors. Approximately 62.43% of the company’s stock is owned by Institutional Investors, 22.31% is owned by Insiders, and 15.25% is owned by Public Companies and Individual Investors.
The ownership structure of Rapport Therapeutics, Inc. (RAPP) stock is a mix of institutional, retail, and individual investors. Approximately 53.48% of the company’s stock is owned by Institutional Investors, 22.31% is owned by Insiders, and 8.95% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 09, 2026
xxxxxxxxxxxxx
$58265
Sep 15, 2025
xxxxxxxxxxxxx
$499188
Sep 15, 2025
xxxxxxxxxxxxx
$1026824
Sep 11, 2025
xxxxxxxxxxxxx
$79100

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2026
xxxxxxxxxxxxx
$32225161
Jun 30, 2026
xxxxxxxxxxxxx
$4064367

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
7,249,743Insider15.11%353,569,966
3,634,580Institution7.58%177,258,467
3,152,816Institution6.57%153,762,836
1,995,594Insider4.16%97,325,119
1,680,682Institution3.50%81,966,861
1,677,281Institution3.50%81,800,994
1,547,090Institution3.22%75,451,579
1,292,696Institution2.69%63,044,784
773,342Institution1.61%37,715,889
756,773Institution1.58%36,907,819

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,634,580Institution7.58%177,258,467
3,152,816Institution6.57%153,762,836
1,292,696Institution2.69%63,044,784
756,773Institution1.58%36,907,819
601,105Institution1.25%29,315,891
364,351Institution0.76%17,769,398
331,722Institution0.69%16,178,082
305,167Institution0.64%14,882,995
297,702Institution0.62%14,518,927
164,405Institution0.34%8,018,032

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
986,730Institution2.06%40,436,195
793,949Institution1.65%38,720,893
331,810Institution0.69%13,597,574
266,251Institution0.55%12,985,061
213,687Institution0.45%10,421,515
187,420Institution0.39%9,526,559
171,907Institution0.36%7,044,749
136,873Institution0.29%6,957,255
110,113Institution0.23%5,597,044
105,624Institution0.22%5,151,282

FAQ

Who Owns Rapport Therapeutics, Inc. (RAPP)?
According to the latest TipRanks data, approximately 29.16% of the company's stock is held by institutional investors, 22.31% is held by insiders, and 15.25% is held by retail investors.
    What percentage of Rapport Therapeutics, Inc. (RAPP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 29.16% of Rapport Therapeutics, Inc. (RAPP) stock is held by institutional investors.
      What percentage of Rapport Therapeutics, Inc. (RAPP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 15.25% of Rapport Therapeutics, Inc. (RAPP) stock is held by retail investors.
        Who owns the most shares of Rapport Therapeutics, Inc. (RAPP)?
        Third Rock Ventures V, L.P. owns the most shares of Rapport Therapeutics, Inc. (RAPP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.